What is the risk of esophageal injury for patients taking alendronate, risedronate, ibandronate, or etidronate?

MOspace/Manakin Repository

Breadcrumbs Navigation

What is the risk of esophageal injury for patients taking alendronate, risedronate, ibandronate, or etidronate?

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/7280

[+] show full item record


Title: What is the risk of esophageal injury for patients taking alendronate, risedronate, ibandronate, or etidronate?
Author: Cable, Julie; Kraus, Connie
Keywords: bisphosphonates
Date: 2008-01
Publisher: Family Physicians Inquiries Network
Citation: Evidence Based Practice 11(1): 07-08.
Series/Report no.: Help Desk Answers
Abstract: In prospective trials, use of alendronate and risedronate resulted in a rate of esophageal injury similar to that of placebo (SOR A, based on systematic reviews of RCTs). Although less evidence is available regarding etidronate and ibandronate, both appear to also have low risk of causing esophageal injury (SOR B, based on a single RCT).
URI: http://hdl.handle.net/10355/7280

This item appears in the following Collection(s)

[+] show full item record